Prostate Cancer
Showing NaN - NaN of 185
Prostate Cancer Trial in London, Carlisle (TURP, UroLift)
Recruiting
- Prostate Cancer
- TURP
- UroLift
-
London, Lon, United Kingdom
- +2 more
Apr 24, 2023
Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)
Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)
Recruiting
- Prostate Cancer
- talazoparib plus enzalutamide
- Placebo plus enzalutamide
-
Birmingham, Alabama
- +306 more
Jan 18, 2023
Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)
Completed
- Prostate Cancer
- 70.2 Gy 3D-CRT/IMRT
- 79.2 Gy 3D-CRT/IMRT
-
Long Beach, California
- +85 more
Dec 27, 2022
Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)
Recruiting
- Small Cell Lung Cancer
- +8 more
- ladiratuzumab vedotin
- pembrolizumab
-
Chandler, Arizona
- +65 more
Dec 19, 2022
Prostate Cancer Trial in Canada (PSMA PET/CT guided intensification of therapy, Control Arm)
Recruiting
- Prostate Cancer
- PSMA PET/CT guided intensification of therapy
- Control Arm
-
Kelowna, British Columbia, Canada
- +13 more
Dec 14, 2022
Prostate Cancer Trial in United Kingdom (NeuroSAFE procedure, Standard RARP)
Active, not recruiting
- Prostate Cancer
- NeuroSAFE procedure
- Standard RARP
-
Bristol, United Kingdom
- +4 more
Dec 12, 2022
Prostate Cancer Trial in London (177Lu-PNT2002, High Dose Radiation)
Recruiting
- Prostate Cancer
- 177Lu-PNT2002
- High Dose Radiation
-
London, Ontario, CanadaLondon Health Sciences Centre
Nov 22, 2022
Breast Cancer, Prostate Cancer, Quality of Life Trial in Worldwide (ASCAPE-based follow-up strategy)
Recruiting
- Breast Cancer
- +4 more
- ASCAPE-based follow-up strategy
-
Athens, Greece
- +4 more
Oct 28, 2022
Stratification in Early Prostate Cancer to Discriminate
Active, not recruiting
- Prostate Cancer
- NA (Observational)
-
London, United KingdomUniversity College Hospital
Oct 25, 2022
Prostate Cancer, Cardiovascular Disease Trial in Canada (Nutrition, Exercise, Smoking cessation)
Recruiting
- Prostate Cancer
- Cardiovascular Disease
- Nutrition
- +4 more
-
Waratah, New South Wales, Australia
- +37 more
Oct 3, 2022
Prostate Cancer Trial in London (Nivolumab & Ipilimumab)
Active, not recruiting
- Prostate Cancer
- Nivolumab & Ipilimumab
-
London, United KingdomUniversity College London Hospital
Sep 26, 2022
Prostate Cancer Trial (Active Surveillance)
Recruiting
- Prostate Cancer
- Active Surveillance
-
Bedford, United Kingdom
- +4 more
Sep 22, 2022
Prostate Cancer Trial in Worldwide (MRI-guided Transurethral Ultrasound Ablation)
Recruiting
- Prostate Cancer
- MRI-guided Transurethral Ultrasound Ablation
-
Los Angeles, California
- +14 more
Sep 12, 2022
Prostate Cancer Trial in Worldwide (Standard of Care)
Recruiting
- Prostate Cancer
- Standard of Care
-
Birmingham, Alabama
- +107 more
Aug 17, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Radical Prostatectomy
- TULSA Procedure
-
Tarzana, California
- +7 more
Aug 10, 2022
Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)
Active, not recruiting
- Melanoma
- +9 more
- MRx0518 Capsules
- MRx0518/placebo Capsules
-
London, United KingdomImperial College Healthcare NHS Trust
Aug 10, 2022
Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))
Prostate Cancer Trial in London (Luminal Index MRI (LI-MRI), LI-MRI targeted prostate biopsy, Plasma methylation signature
Recruiting
- Prostate Cancer
- Luminal Index MRI (LI-MRI)
- +2 more
-
London, United KingdomUniversity College London Hospitals NHS Foundation Trust
Jul 28, 2022
Prostate Cancer Trial in London
Recruiting
- Prostate Cancer
-
London, United KingdomUniversity College London
Jul 28, 2022